Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Balluff releases BMP magnetic position sensors April 29, 2019 Technosoft introduces iPOS2401 servo drive with EtherCAT interface November 28, 2017 Calex announces QRW series of DC/DC converters December 23, 2017